Jaap van Doesum

16PUBLICATIONS
215CO-AUTHORS
HaematologyPredictive and prognostic markersCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 16, 2025
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL.

Janneke W de Boer, Kylie Keijzer, Suzanne van Dorp

|Jul 23, 2024
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.

Anne Mea Spanjaart, Per Ljungman, Gloria Tridello

|Nov 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.

Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin

|Apr 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.

Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi

|Apr 03, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.

Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio

|Sep 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.

Livio Pagano, Jon Salmanton-García, Francesco Marchesi

Pageof 3

Frequent Collaborators

9 joint publications

Livio Pagano

9 joint publications

Francesco Marchesi

9 joint publications

Jon Salmanton-García

9 joint publications

Oliver A Cornely